GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands Overview

Life ScienceCompany

Where is GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands headquartered?

GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands is headquartered in United Kingdom.

What sector is GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands in?

GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands is a life science company.

GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands


United Kingdom,

GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands is a specialised sterile production site which manufactures the Brands at Notre Dame de Bondeville, France . Arixtra and Fraxiparine/Fraxodi are made at a sterile site and the ability to manufacture steriles is globally recognised as a specialist activity resulting in limited possible competition. This is a factor further underlined by the increased complexity of the manufacturing process of Fraxiparine/Fraxodi due to the biological nature of the active pharmaceutical ingredients (“API”) used in their production.



Try Mergr Free — See This and 220,453+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 82K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for GlaxoSmithKline - Arixtra & Fraxiparine/Fraxodi Brands

Life Science Companies , United Kingdom Companies